ATE414712T1 - Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung - Google Patents

Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung

Info

Publication number
ATE414712T1
ATE414712T1 AT97916104T AT97916104T ATE414712T1 AT E414712 T1 ATE414712 T1 AT E414712T1 AT 97916104 T AT97916104 T AT 97916104T AT 97916104 T AT97916104 T AT 97916104T AT E414712 T1 ATE414712 T1 AT E414712T1
Authority
AT
Austria
Prior art keywords
hiv infection
binding peptide
infection treatment
immunogenic hla
hla
Prior art date
Application number
AT97916104T
Other languages
English (en)
Inventor
Ralph Kubo
Howard Grey
Alessandro Sette
Esteban Celis
Original Assignee
Pharmexa Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/821,739 external-priority patent/US20020168374A1/en
Application filed by Pharmexa Inc filed Critical Pharmexa Inc
Application granted granted Critical
Publication of ATE414712T1 publication Critical patent/ATE414712T1/de

Links

AT97916104T 1996-03-21 1997-03-21 Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung ATE414712T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1383396P 1996-03-21 1996-03-21
US08/821,739 US20020168374A1 (en) 1992-08-07 1997-03-20 Hla binding peptides and their uses

Publications (1)

Publication Number Publication Date
ATE414712T1 true ATE414712T1 (de) 2008-12-15

Family

ID=40076293

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97916104T ATE414712T1 (de) 1996-03-21 1997-03-21 Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung

Country Status (2)

Country Link
AT (1) ATE414712T1 (de)
DE (1) DE69739115D1 (de)

Also Published As

Publication number Publication date
DE69739115D1 (de) 2009-01-02

Similar Documents

Publication Publication Date Title
DE69739758D1 (de) Vakzine zur behandlung von lymphomen und leukämie
GB9609932D0 (en) Use of IL-12 and IFN alpha for the treatment of infectious diseases
DE69230517D1 (de) Zur Aspiration und Irrigation bestimmtes endoskopisches chirurgisches Instrument
IS5191A (is) Örverueyðandi hindrun og meðferð gegn eyðniveirunni og öðrum smitsjúkdómum í mönnum
FI963281A7 (fi) Ureaasipohjainen rokote ja helicobakteeri-infektion hoito
EP0958364A4 (de) Immuntherapie und verbesserte impfstoffe
HUP9901109A3 (en) Peptide immunogens for vaccination against and treatment of allergy
DE69835031D1 (de) Neue anti-hiv immunogene (toxoide), herstellungsverfahren und verwendungen zur behandlung und vorbeugung von aids
ATE363904T1 (de) Benzimidazol-2-carbamat zur behandlung viraler infektionen und von krebs
HUP9901186A2 (hu) Peptid-és adjuvánsalapú gyógyszerkészítmény immunmodulációra
DE69733994D1 (de) Sauger zur medikamentenverabreichung
SI0831921T1 (en) Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection
AU6588598A (en) Treatment of hepatitis b infection with thymosin alpha 1 and famciclovir
FI963252L (fi) Kivun hoitoon tarkoitetut uudet opioidipeptidit ja niiden käyttö
ATE229338T1 (de) 2',2'-difluornucleoside zur immunosuppressiven therapie und kombinationspräparate
DE3770851D1 (de) Streckvorrichtung fuer operationstische und zubehoer fuer orthopaedische chirurgie.
AU2002219881A1 (en) Methods and compositions for the treatment of human immunodeficiency virus infection
IL128847A0 (en) Immunogenic peptides of foot-and-mouth disease viruses
IL154532A0 (en) Vaccine immunogens comprising disulphide bridged cyclised peptide and use thereof in the treatment of allergies
ID21874A (id) Penggunaan 1-hidroksi-2-piridon untuk pengobatan infeksi urap kulit
DE59010105D1 (de) Leukozytenelastase und kathepsin g blockierendes peptid
ATE414712T1 (de) Immunogenes hla-bindendes peptid und verwendung desselben zur hiv-infektionsbehandlung
EP0970965A4 (de) Zyklische peptide und medizinische verwendung davon
DE69334276D1 (de) Immunreaktive peptide des epstein-barrvirus
IL151033A0 (en) Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties